NCT05368805 2022-10-06Fruquintinib DDI Study With P-gp and BCRP SubstratesHutchmedPhase 1 Completed32 enrolled
NCT03977090 2021-02-10Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal CancerGenor Biopharma Co., Ltd.Phase 1 Unknown21 enrolled